僅用于工業(yè)應(yīng)用或科學(xué)研究，不可用于人類或動物的臨床診斷或治療，非藥用. Telisotuzumab （ABT-700） is a human recombinant bivalent antibody, a therapeutic antibody against the hepatocyte growth factor receptor （MET） that binds c-Met with high affinity and inhibits c-Met signaling. Telisotuzumab has antitumor activity